Cargando…
Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
Patients with systemic sclerosis complicated by both pulmonary hypertension (SSc‐PH) and interstitial lung disease (SSc‐PH‐ILD) have poor prognosis compared to those with SSc‐PH or SSc‐ILD alone. Little is known of how ILD severity affects outcomes in those with SSc‐PH, or how PH severity affects ou...
Autores principales: | Sangani, Ruchika A., Lui, Justin K., Gillmeyer, Kari R., Trojanowski, Marcin A., Bujor, Andreea M., LaValley, Michael P., Klings, Elizabeth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535436/ https://www.ncbi.nlm.nih.gov/pubmed/36238967 http://dx.doi.org/10.1002/pul2.12117 |
Ejemplares similares
-
Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
por: Gillmeyer, Kari R., et al.
Publicado: (2022) -
Outcomes of pulmonary vasodilator use in Veterans with pulmonary
hypertension associated with left heart disease and lung disease
por: Gillmeyer, Kari R., et al.
Publicado: (2021) -
Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis
por: Bujor, Andreea M., et al.
Publicado: (2019) -
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022) -
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)